Neurocognitive testing in late-onset Tay-Sachs disease: A pilot study

D. Elstein*, G. M. Doniger, E. Simon, I. Korn-Lubetzki, R. Navon, A. Zimran

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Objectives: To test neurocognitive function in patients with late-onset Tay-Sachs disease (LOTS) using a computerized system to assess whether cognition is a clinically relevant outcome measure of possible therapeutic intervention in LOTS. Methods: Ten adults with Tay-Sachs disease were administered at least one battery of the Mindstreams Neurotrax system for evaluation of cognitive function. Six sub-scores and a Global Cognitive Score (GCS) were tabulated. A disease specific severity score was also devised with six domains. Results: Despite identical genotypes, all patients but the two oldest had ≥3/6 sub-scores one standard deviation below normal mean (100); verbal and executive functions were most affected. The severity score measured other functions. Conclusions: Because of provocative findings on re-testing in patients exposed to miglustat, and despite the very small cohort, cognitive function may be an appropriate and clinically relevant outcome measure for future therapeutic interventions in LOTS.

Original languageEnglish
Pages (from-to)518-523
Number of pages6
JournalJournal of Inherited Metabolic Disease
Issue number4
StatePublished - 2008


Dive into the research topics of 'Neurocognitive testing in late-onset Tay-Sachs disease: A pilot study'. Together they form a unique fingerprint.

Cite this